Abstract
Over the last decade our understanding of human gut microbiology underwent a tremendous transformation. The limitations of culture-based methods have given way to Next Generation Sequencing techniques, allowing us to understand the microbial gut community in greater depth. The human GI-tract harbours one of the most complex and abundant ecosystems colonized by more than 100 trillion microorganisms, among which Firmicutes and Bacteroidetes are the major phyla. Although stable over long periods, the composition and functions of the microbiome may be influenced by a number of factors including genetics, mode of delivery, age, diet, geographic location and medical treatments. Dysbiosis, changes in microbiome structure, has been linked to inflammatory, functional and metabolic disorders such as IBD, IBS and obesity. However, it is still not clear whether these changes are a contributing factor or a result of the disease. This synopsis provides a chronological overview of the techniques used to study the gut microbiota and the current knowledge with respect to the stability and variability of microbiome composition and functions.
Keywords: 16S rRNA, composition, diversity, gastrointestinal tract, human gut microbiota, metagenomics, microbiome, sequencing.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Structure and Functions of the Gut Microbiome
Volume: 14 Issue: 4
Author(s): Suchita Panda, Francisco Guarner and Chaysavanh Manichanh
Affiliation:
Keywords: 16S rRNA, composition, diversity, gastrointestinal tract, human gut microbiota, metagenomics, microbiome, sequencing.
Abstract: Over the last decade our understanding of human gut microbiology underwent a tremendous transformation. The limitations of culture-based methods have given way to Next Generation Sequencing techniques, allowing us to understand the microbial gut community in greater depth. The human GI-tract harbours one of the most complex and abundant ecosystems colonized by more than 100 trillion microorganisms, among which Firmicutes and Bacteroidetes are the major phyla. Although stable over long periods, the composition and functions of the microbiome may be influenced by a number of factors including genetics, mode of delivery, age, diet, geographic location and medical treatments. Dysbiosis, changes in microbiome structure, has been linked to inflammatory, functional and metabolic disorders such as IBD, IBS and obesity. However, it is still not clear whether these changes are a contributing factor or a result of the disease. This synopsis provides a chronological overview of the techniques used to study the gut microbiota and the current knowledge with respect to the stability and variability of microbiome composition and functions.
Export Options
About this article
Cite this article as:
Panda Suchita, Guarner Francisco and Manichanh Chaysavanh, Structure and Functions of the Gut Microbiome, Endocrine, Metabolic & Immune Disorders - Drug Targets 2014; 14 (4) . https://dx.doi.org/10.2174/1871530314666140714120744
DOI https://dx.doi.org/10.2174/1871530314666140714120744 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Desmopressin 30 Years in Clinical Use: A Safety Review
Current Drug Safety Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression
Current Molecular Medicine The Co-agonist Site of NMDA-glutamate Receptors: A Novel Therapeutic Target for Age-related Cognitive Decline
Current Pharmaceutical Design FGF10 and FGF21 as Regulators in Adipocyte Development and Metabolism
Endocrine, Metabolic & Immune Disorders - Drug Targets Targets for Steroid Hormone Mediated Actions of Periodontal Pathogens, Cytokines and Therapeutic Agents Some Implications on Tissue Turnover in the Periodontium
Current Drug Targets Current Genomics in Cardiovascular Medicine
Current Genomics A Closer Look at α-Secretase
Current Alzheimer Research Cellular Iron Homeostasis and Therapeutic Implications of Iron Chelators in Cancer
Current Pharmaceutical Biotechnology Pathophysiology of Neurodegeneration in Familial Amyotrophic Lateral Sclerosis
Current Molecular Medicine Anti-cancer and Anti-angiogenic Properties of Various Natural Pentacyclic Tri-terpenoids and Some of their Chemical Derivatives
Current Organic Chemistry Receptor-Based Design of Cytokine Therapeutics
Current Pharmaceutical Biotechnology The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters
Anti-Cancer Agents in Medicinal Chemistry Phosphodiesterase 5 Inhibitors in the Treatment of Erectile Dysfunction
Current Pharmaceutical Design Non-Analgesic Effects of Opioids: Management of Opioid-Induced Constipation by Peripheral Opioid Receptor Antagonists: Prevention or Withdrawal?
Current Pharmaceutical Design Appropriate Application of Evidence to the Care of Elderly Patients with Diabetes
Current Diabetes Reviews The Multifactorial Nature of Alzheimer's Disease for Developing Potential Therapeutics
Current Topics in Medicinal Chemistry Dry Eyes in Rheumatic Disease
Current Rheumatology Reviews Managing Sleep Disturbance in Bipolar Disorder
Current Psychiatry Reviews Drug Induced Cutaneous Manifestations due to Treatment of Gastrointestinal Disorders
Current Drug Metabolism Racial/Ethnic Differences in Symptoms of Posttraumatic Stress Disorder
Current Psychiatry Reviews